Research on the Construction of Cord Blood Storage Decision Aid Network Platform Based on "Internet +"

Sponsor
Qianfoshan Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT06001905
Collaborator
Shandong Nursing Association (Other)
400
1
24
16.7

Study Details

Study Description

Brief Summary

Cord blood, as an important alternative source of hematopoietic stem cells, can be used to reconstruct bone marrow hematopoietic and immune function, and is an effective means to treat children with blood diseases. However, at present, the collection rate of cord blood is not high in our country, only the mother have the right to decide whether or not. At the same time, domestic studies on cord blood collection are still very limited, for the lack of effective programs and policies, which can not provide help to improve the collection level of cord blood. Therefore, in order to improve the rate of umbilical cord blood collection, it is particularly necessary to build tools to help pregnant women decide whether to retain cord blood. This topic will investigate and analyze the cognition and retention intention of pregnant women for umbilical cord blood collection. At the same time, the related process of pregnant women for umbilical cord blood retention will be deeply explored. Based on the results of quantitative and qualitative investigation, Internet technology will be used to build a network platform for pregnant women for umbilical cord blood storage decision AIDS, and the effectiveness of this tool will be evaluated. To provide theoretical basis for clinical medical workers and umbilical cord blood bank staff to establish the decision plan of cord blood storage.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    400 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Research on the Construction of Cord Blood Storage Decision Aid Network Platform Based on "Internet +"
    Actual Study Start Date :
    Jul 10, 2022
    Anticipated Primary Completion Date :
    Jul 10, 2024
    Anticipated Study Completion Date :
    Jul 10, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Construct the network platform of cord blood storage decision aid tool [2024.07.10]

      Construct the network platform of cord blood storage decision aid tool based on "Internet +" and apply it to clinical practice to provide support and help for pregnant women in cord blood storage decision, avoid decision regret, and improve pregnant women's willingness and satisfaction in cord blood storage.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age > 18 years old;

    • Pregnant women whose gestational age ≥12 weeks and registered in our hospital;

    • With a certain level of education, can complete the questionnaire independently;

    • Informed consent to participate in the study

    Exclusion Criteria:
    • There are patients with mental illness;

    • Participated in other clinical studies in the past three months.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Zhongguo Jinan China 250014

    Sponsors and Collaborators

    • Qianfoshan Hospital
    • Shandong Nursing Association

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hong Ji, chief superintendent nurse, Qianfoshan Hospital
    ClinicalTrials.gov Identifier:
    NCT06001905
    Other Study ID Numbers:
    • YXLL-KY-2023(059)
    First Posted:
    Aug 21, 2023
    Last Update Posted:
    Aug 21, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Aug 21, 2023